In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 26 for your search:
Cancer Type/Condition:  Breast cancer, female
Trial Type:  Prevention
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 69
Sponsor: Other
Protocol IDs: UC-0104/0701 - ONCO03, ONCO-03/0701, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, 2007-000687-24, FNCLCC-ONCO-03/0701, FNCLCC-ONCO 03/0701 - LIBER, NCT00673335
2.

Phase: Phase III
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ACCOG-HER-PCI, ACCOG-HER-PCI, ISRCTN64624715, EU-20822, NCT00639366
3.

Phase: Phase III
Type: Prevention
Status: Active
Age: 30 to 75
Sponsor: Other
Protocol IDs: GD-10-08, NCT00808522
4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: GAL 01, NCT01357772
5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 74
Sponsor: Other
Protocol IDs: ACF:24404, NCT01435005
6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200806, NCT01425476
7.

Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 90
Sponsor: Other
Protocol IDs: 102/07 (HT4351), NCT00496288
8.

Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 69
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: 10587, CFEM345AUS45, 5R01CA122577-03, NCT00579826
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 35 to 55
Sponsor: Other
Protocol IDs: V0407, CHRMS#: 05-059, NCT00914017
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 64
Sponsor: Other
Protocol IDs: 0806M36121, NCT00917735
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI
Protocol IDs: SWOG-S0812, S0812, NCT01097278
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 25 and over
Sponsor: NCI, Other
Protocol IDs: 08218, R01CA140245-01, NCI-2010-01976, NCT01196936
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 to 49
Sponsor: Other
Protocol IDs: 12377, NCT01276704
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-0794, NCT01471106
15.

Phase: Phase II
Type: Prevention
Status: Active
Age: Not Specified
Sponsor: Other
Protocol IDs: Institut Jules Bordet, NCT01658956
16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 25 to 45
Sponsor: Other
Protocol IDs: 2009-015-B, NCT01022333
17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Postmenopausal
Sponsor: NCI
Protocol IDs: NCI-2011-00949, 09-0869-04, CDR0000666604, UARIZ-09-0869-04, UARIZ-UAZ08-12-02, NCT01077453
18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10024, NCT01282580
19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000581219, P30CA015083, MC0536, 06-002061, MAYO-MC0536, NCT00611104
20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 20 to 40
Sponsor: NCI, Other
Protocol IDs: CDR0000597679, FCCC-06827, 06-827, NCT00700778
21.

Phase: No phase specified
Type: Prevention
Status: Active
Age: 35 to 70
Sponsor: Other
Protocol IDs: 26970, NCT00723398
22.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 70
Sponsor: Other
Protocol IDs: PHO-0702, NCT01127867
23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 55 and under
Sponsor: NCI
Protocol IDs: CALGB-70806, CALGB 70806, NCT01224678
24.

Phase: No phase specified
Type: Diagnostic, Prevention, Treatment
Status: Active
Age: 30 to 75
Sponsor: NCI, Other
Protocol IDs: 1B-10-6, NCI-2010-01847, NCT01219075
25.

Phase: No phase specified
Type: Prevention
Status: Active
Age: 18 to 35
Sponsor: Other
Protocol IDs: HS-10-00455, NCT01318005
1   
New Search